Health Care Plans Stocks under Review -- Aetna, Cigna, Humana, Anthem, and Centene

Aug 06, 2015, 09:10 ET from www.equityresearchinstitute.com

NEW YORK, August 6, 2015 /PRNewswire/ --

Equity Research Institute has initiated coverage on the following equities: Aetna Inc. (NYSE: AET), Cigna Corporation (NYSE: CI), Humana Inc. (NYSE: HUM), Anthem Inc. (NYSE: ANTM), and Centene Corporation (NYSE: CNC). Free research report on Aetna can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=AET On Wednesday, August 05, 2015, the NASDAQ Composite ended at 5,139.94, up 0.67%, the Dow Jones Industrial Average edged 0.06% lower, to finish the day at 17,540.47, and the S&P 500 closed at 2,099.84, up 0.31%. The gains were broad based as six out of nine sectors ended the session in positive. Register for your complimentary reports at the links given below.  

Aetna Inc.'s stock advanced 2.50%, to close the day at $118.07. The stock recorded a trading volume of 4.30 million shares, much above its three months average volume of 3.46 million shares. Over the last one month and over the past three months, Aetna Inc.'s shares have gained 2.60% and 10.21%, respectively. Furthermore, the stock has surged 33.89% since the start of this year. The company's shares are trading 0.16% above their 50-day moving average and 16.46% above their 200-day moving average. Additionally, Aetna Inc. traded at a PE ratio of 19.52 and has a Relative Strength Index (RSI) of 58.32. Sign up and read the free notes on AET at:

https://www.EquityResearchInstitute.com/reports?keyword=AET

On Wednesday, shares in Cigna Corp. recorded a trading volume of 3.50 million shares, higher than their three months average volume of 3.12 million shares. The stock ended the day 2.54% higher at $147.55. Shares of the company traded at a PE ratio of 18.44. Although, Cigna Corp.'s stock has lost 4.46% in the last one month, it has surged 17.77% in the previous three months and 43.42% on YTD basis. The company is trading above its 200-day moving average by 19.64%. Furthermore, shares of Cigna Corp. have an RSI of 48.48. The complimentary notes on CI can be downloaded in PDF format at:

https://www.EquityResearchInstitute.com/reports?keyword=CI

Humana Inc.'s stock gained 1.76%, to close Wednesday's session at $185.54. The stock recorded a trading volume of 1.32 million shares, below its three months average volume of 2.75 million shares. Over the previous three months and since the beginning of 2015, Humana Inc.'s shares have surged 13.95% and 29.58%, respectively. However, the stock has lost 0.83% in the last one month. The company is trading 12.51% above its 200-day moving average. Furthermore, Humana Inc.'s stock traded at a PE ratio of 21.91 and has an RSI of 43.22. Register for free on Equity Research Institute and access the latest research on HUM at:

https://www.EquityResearchInstitute.com/reports?keyword=HUM

Anthem Inc.'s stock finished Wednesday's session 1.61% higher at $154.95. A total of 2.22 million shares were traded, which was close to its three months average volume of 2.10 million shares. Over the last one month and the previous three months, Anthem Inc.'s shares have fallen by 3.36% and 2.69%, respectively. However, the stock has surged 24.30% since the beginning of 2015. The company's shares are trading above their 200-day moving average by 7.33%. Anthem Inc.'s stock traded at a PE ratio of 15.13 and has an RSI of 45.90. The complete research on ANTM is available for free at:

https://www.EquityResearchInstitute.com/reports?keyword=ANTM

On Wednesday, shares in Centene Corp. ended the session 1.38% higher at $71.46. The stock reported a trading volume of 1.49 million shares, below its three months average volume of 1.79 million shares. Shares of the company traded at a PE ratio of 25.71. Centene Corp.'s shares have advanced 1.77% in the last one month, 12.45% in the previous three months and 37.62% on YTD basis. The company is trading 14.98% above its 200-day moving average. Moreover, shares of Centene Corp. have an RSI of 48.32. Free in-depth research on CNC is available at:

https://www.EquityResearchInstitute.com/reports?keyword=CNC

--

About Equity Research Institute: 

Equity Research Institute ("ERI") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ERI has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ERI has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:  

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the CFA® have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the CFA® (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY 

ERI, the Author, the Reviewer and the CFA® (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ERI nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.equityresearchinstitute.com.

RESTRICTIONS 

ERI is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia. Do not send email to robottrap (at) equityresearchinstitute.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE www.equityresearchinstitute.com